Gilead prices COVID-19 drug remdesivir at $2\,340 per patient

Gilead prices COVID-19 drug remdesivir at $2,340 per patient

Jerusalem Post Tuesday, 30 June 2020 ()
Gilead prices COVID-19 drug remdesivir at $2,340 per patientRemdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19.
0
shares
 
Video credit: GeoBeats - Published
News video: Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:44

 Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.